MedPath

Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Completed
Conditions
Atopic Dermatitis
Atopic Dermatitis Eczema
Eczema
Registration Number
NCT03823794
Lead Sponsor
Momentum Data
Brief Summary

Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used.

Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently.

Detailed Description

Objective

The study aims to describe the health care resource utilisation of patients with active AD in terms of prescription use, primary care appointments, and specialist referrals.

Method This study will define AD cases using a previously validated algorithm for case identification use clinical codes form primary care in the UK (Read codes). The study will analyse a cohort of prevalent active AD cases over a one year period (2018). The annual use of topical and oral medications used for the treatment of AD, primary care appointments, and specialist referrals will be reported.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148166
Inclusion Criteria
  • All paediatric and adult patients registered with an Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) contributing GP practice during the study period (2008-2018) and with at least one year of follow-up.
Exclusion Criteria
  • The presence of psoriasis, photodermatitis, or ichthyosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prescription Rates for Atopic Dermatitis Related Treatments: Mild Topical Corticosteroids (TCS)Jan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for mild topical corticosteroids (atopic dermatitis related treatment)

Prescription Rates for Atopic Dermatitis Related Treatments: Topical AntimicrobialsJan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for topical antimicrobials.

Prescription Rates for Atopic Dermatitis Related Treatments: Emollients and Soap SubstitutesJan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for emollients and soap substitutes.

Prescription Rates for Atopic Dermatitis Related Treatments: Moderate Topical Corticosteroids (TCS)Jan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for moderate topical corticosteroids (an atopic dermatitis related treatment)

Prescription Rates for Atopic Dermatitis Related Treatments: Potent Topical Corticosteroids (TCS)Jan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for potent topical corticosteroids (an atopic dermatitis related treatment)

Prescription Rates for Atopic Dermatitis Related Treatments: Very Potent Topical Corticosteroids (TCS)Jan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for very potent topical corticosteroid (an atopic dermatitis related treatment)

Prescription Rates for Atopic Dermatitis Related Treatments: Topical Calcineurin Inhibitors (TCI)Jan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for a topical Calcineurin Inhibitor (an atopic dermatitis related treatment)

Specialist ReferralsJan - Dec 2018 inclusive

Specialist dermatology referral rate in 2018

Prescription Rates for Atopic Dermatitis Related Treatments: AntihistaminJan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for antihistamin.

Prescription Rates for Atopic Dermatitis Related Treatments: Systemic Immuno-modulatory TherapyJan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for Systemic immuno-modulatory therapy

Prescription Rates for Atopic Dermatitis Related Treatments: Oral CorticosteroidsJan - Dec 2018 inclusive

Proportion of the arm/group receiving at least one prescription for oral corticosteroids

Primary Care ReferralsJan - Dec 2018 inclusive

Annual rate of primary care consultations in 2018

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Momentum Data Ltd

🇬🇧

London, United Kingdom

Momentum Data Ltd
🇬🇧London, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.